1. TFOS Ambassadors

Poland

Malgorzata Mrugacz

Dr. Malgorzata Mrugacz M.D., Ph.D. is Professor of Ophthalmology and Head of the Department of Ophthalmology and Eye Rehabilitation at Medical University of Bialystok, Poland. She is an ophthalmologist with a special interest in ocular surface diseases and dry eye involved in ocular surface immunology. She is also  interested in diagnosis and treatment retinal changes in patients with myopia and glaucoma. Clinical practice includes an interest in the management of amblyopia and using strabismus surgery and botulinum toxin to treat strabismus.  In addition to research, Prof. Mrugacz concentrates extensively on teaching medical students in ophthalmology and eye research.

Dr. Mrugacz has published over 250 peer- reviewed  articles and served as the Editorial Board Member for a number of journals including Progress in Health Sciences, Journal of Ophthalmology and Optometry, Journal of Ophthalmology and Clinical Research. She is a member of Polish Ophthalmological Society, Polish Electrophysiology Society, European Pediatric Ophthalmology Society, European Association for Vision and Eye Research,   American Academy of Ophthalmology, New York Academy of Sciences, and Doctors Without Borders. She identifies with the quote of Hippocrates: “Wherever the art of Medicine is loved, there is also a love of Humanity”.

She enjoys spending time with her family, including dog. She also enjoys biking, skiing and the simple joys of life.
 
< back

20 April

TFOS Guidelines

Ocular surface disease (OSD)—including dry eye disease, blepharitis, meibomian gland dysfunction, conjunctival inflammation, and cicatrizing ocular surface disorders—is one of the most common and underrecognized factors affecting the success of eye surgery (e.g., refractive, cataract, glaucoma, strabismus, retina, and oculoplastic). Conversely, optimizing the ocular surface is one of the most effective, modifiable strategies for enhancing surgical success across all ophthalmic subspecialties. And the central clinical principle appears to be universal: elective eye surgery...

17 April

EssilorLuxottica Partners with TFOS to Advance Ocular Surface Health Worldwide

TFOS is pleased to announce a new strategic partnership with EssilorLuxottica, a global leader in vision care and eyewear. This collaboration will support shared efforts to elevate awareness, education, and scientific progress in tear film and ocular surface health worldwide. By combining TFOS’s expertise in evidence-based consensus and professional education with EssilorLuxottica’s global reach and innovation capabilities, the partnership aims to help improve standards of care for patients affected by dry eye disease and related ocular surface conditions. Together, TFOS and EssilorLuxottica...

10 February

Latin American TFOS Ambassador Meeting

TFOS has organized a special meeting of the Latin American TFOS Ambassadors. This meeting, which will occur in Panama City this May, has two goals: first, to address the unmet needs for the management (e.g. diagnosis & treatment) of ocular surface diseases in their country/region, as well as what the Ambassadors perceive as short and long term scientific/clinical solutions; and second, to create a report for publication in a peer-reviewed journal. Participants will include TFOS Ambassadors from Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras,...

Corporate Advisory Board Members